lundi 2 mai 2016

Onco Actu du 2 mai 2016

3.1 Tabac

Australia’s prohibition of e-cigarettes is out of step with the evidence [The Conversation]

Can e-cigarette makers stub out addiction concerns? [The Guardian]

3.6 Prévention - Activité physique

Why you shouldn't exercise to lose weight, explained with 60+ studies [Vox]

4.12 Biopsies liquides

Blood biopsy: Releasing cancer cells for better analysis [University of Michigan]

5. Traitements

New drugs for aggressive prostate cancer 'promising' [BBC News]

5.2 Pharma

Q1 2016 Results [AstraZeneca]

AstraZeneca cuts costs and doubles down on cancer drugs [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

CHMP recommends EU approval for Roche’s Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer [Roche]

Janssen’s IMBRUVICA® (ibrutinib) Receives Positive CHMP Opinion for Expanded Use in Previously Untreated Chronic Lymphocytic Leukaemia Patients [Johnson & Johnson]

Novartis drug Afinitor® recommended by CHMP for European Union approval to treat select GI and lung neuroendocrine tumors [Novartis]

CHMP recommends EU approval of Roche’s Gazyvaro for people with previously treated follicular lymphoma [Roche]

New treatment for rare white blood cell cancer [EMA]

6.10 Politiques

The Moonshot: A View from Europe [The Cancer Letter]

Joe Biden Speaks About Faith and Curing Cancer at the Vatican [NY Times]

Biden gets papal blessing for his global war on cancer [Reuters]

6.6 Publications

Step by Step: Collecting and Connecting ORCID iDs in the Publishing Process [ORCID]

Seeing double: Duplicated images plague research papers [STAT]

6.8 Communication

U2 guitarist The Edge makes history as he rocks Sistine Chapel for cancer [Reuters]